| Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility A Schroeder, Y Avnir, S Weisman, Y Najajreh, A Gabizon, Y Talmon, ... Langmuir 23 (7), 4019-4025, 2007 | 280 | 2007 |
| Interactions of cisplatin and transplatin with proteins: Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin … T Peleg-Shulman, Y Najajreh, D Gibson Journal of inorganic biochemistry 91 (1), 306-311, 2002 | 145 | 2002 |
| DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media … J Kasparkova, V Marini, Y Najajreh, D Gibson, V Brabec Biochemistry 42 (20), 6321-6332, 2003 | 144 | 2003 |
| Novel Soluble Cationic trans-Diaminedichloroplatinum(II) Complexes that Are Active against Cisplatin Resistant Ovarian Cancer Cell Lines Y Najajreh, JM Perez, C Navarro-Ranninger, D Gibson Journal of medicinal chemistry 45 (24), 5189-5195, 2002 | 128 | 2002 |
| Facile Preparation of Mono‐, Di‐and Mixed‐Carboxylato Platinum (IV) Complexes for Versatile Anticancer Prodrug Design JZ Zhang, P Bonnitcha, E Wexselblatt, AV Klein, Y Najajreh, D Gibson, ... Chemistry–A European Journal 19 (5), 1672-1676, 2013 | 121 | 2013 |
| Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action S Schoof, G Pradel, MN Aminake, B Ellinger, S Baumann, M Potowski, ... Angewandte Chemie International Edition, 3317-3321, 2010 | 98 | 2010 |
| Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis H Cohen-Sacks, Y Najajreh, V Tchaikovski, G Gao, V Elazer, R Dahan, ... Gene therapy 9 (23), 1607-1616, 2002 | 88 | 2002 |
| Novel Apoptosis-Inducing trans-Platinum Piperidine Derivatives: Synthesis and Biological Characterization E Khazanov, Y Barenholz, D Gibson, Y Najajreh Journal of medicinal chemistry 45 (24), 5196-5204, 2002 | 87 | 2002 |
| Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand: Mechanistic studies on antitumor action J Kasparkova, O Novakova, V Marini, Y Najajreh, D Gibson, JM Perez, ... Journal of Biological Chemistry 278 (48), 47516-47525, 2003 | 78 | 2003 |
| Ligand effects on the binding of cis- and trans-[PtCl2Am1Am2] to proteins Y Najajreh, T Peleg-Shulman, O Moshel, N Farrell, D Gibson JBIC Journal of Biological Inorganic Chemistry 8, 167-175, 2003 | 49 | 2003 |
| Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum PA Nguewa, MA Fuertes, S Iborra, Y Najajreh, D Gibson, E Martínez, ... Journal of inorganic biochemistry 99 (3), 727-736, 2005 | 45 | 2005 |
| Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells H Adwan, T Bäuerle, Y Najajreh, V Elazer, G Golomb, MR Berger International journal of oncology 24 (5), 1235-1244, 2004 | 44 | 2004 |
| Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy … Y Najajreh, E Khazanov, S Jawbry, Y Ardeli-Tzaraf, JM Perez, ... Journal of medicinal chemistry 49 (15), 4665-4673, 2006 | 40 | 2006 |
| Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand Y Najajreh, J Kasparkova, V Marini, D Gibson, V Brabec JBIC Journal of Biological Inorganic Chemistry 10, 722-731, 2005 | 32 | 2005 |
| Structure and Unique Interactions with DNA of a Cationic Trans‐Platinum Complex with the Nonplanar Bicyclic Piperidinopiperidine Ligand Y Najajreh, D Prilutski, Y Ardeli‐Tzaraf, JM Perez, E Khazanov, ... Angewandte Chemie International Edition 44 (19), 2885-2887, 2005 | 32 | 2005 |
| Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study E Ratzon, Y Najajreh, R Salem, H Khamaisie, M Ruthardt, J Mahajna BMC cancer 16, 1-11, 2016 | 31 | 2016 |
| Chemistry and applications of benzimidazole and its derivatives M Marinescu BoD–Books on Demand, 2019 | 30 | 2019 |
| Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism M Khateb, N Ruimi, H Khamisie, Y Najajreh, A Mian, A Metodieva, ... BMC cancer 12, 1-10, 2012 | 28 | 2012 |
| Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I AA Mian, A Metodieva, S Badura, M Khateb, N Ruimi, Y Najajreh, ... BMC cancer 12, 1-8, 2012 | 28 | 2012 |
| CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity F Alotaibi, M Rytelewski, R Figueredo, R Zareardalan, M Zhang, ... European journal of immunology 50 (5), 695-704, 2020 | 25 | 2020 |
yechezkel barenholzhebrew university of jerusalemVerified email at ekmd.huji.ac.il
